Skip to content

Comparison of Clinical Outcomes According to High-protein Provision in Critically Ill Patients After Abdominal Surgery

Comparison of Clinical Outcomes According to High-protein Provision Through Parenteral Nutrition in Critically Ill Patients Immediately After Abdominal Surgery: a Prospective, Single-blinded, Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06458387
Enrollment
152
Registered
2024-06-13
Start date
2024-07-31
Completion date
2027-06-30
Last updated
2024-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protein Malnutrition

Brief summary

Protein malnutrition in critically ill patients is a global concern due to its association with prolonged hospital stays, and higher morbidity rates. Patients who undergo abdominal surgery are particularly vulnerable due to alterations in gastrointestinal function and prolonged fasting. Despite the significance of proper nutrition, the optimal target of protein supplementation remains controversial. The investigators aimed to evaluate the effects of high protein provision, targeting a protein intake of at least 1.5 g/kg/day for the first 3 days after abdominal surgery, on 6-month mortality.

Detailed description

During the acute phase of critical illness, patients experience metabolic and physiological changes that affects their nutrition status. One prominent feature is the activation of stress hormones and inflammatory mediators, which contribute to a negative nitrogen balance, increased gluconeogenesis, and accelerated muscle proteolysis. Among these patients, those who undergo abdominal surgery are particularly vulnerable to malnutrition as they experience alterations in the structural barrier of the gastrointestinal tract, impaired nutrient absorption, and prolonged fasting due to concerns such as the integrity of an anastomosis. Thus, appropriate protein provision should be prioritized for critically ill patients following abdominal surgery, and it should include adequate nutritional support to preserve lean body mass and organ function. Despite the importance of nutritional supply, the recommendations for protein vary according to different guidelines, and this is the same for surgical patients. Recent randomized controlled trials reported conflicting results with current guidelines, with some suggesting that higher protein dose administrations did not significantly impact clinical outcomes and may even worsen the outcomes for certain patient groups. Thus, the optimal protein provision target during the acute phase of critical illness, particularly for surgical patients, remains controversial. The investigators aimed to assess the effects of strict high protein provision between the high protein group (protein target supplemented with 1.5 g/kg/day) and the control group (protein target supplemented with less than 1.5 g/kg/day) using intravenous nutrient solution for the first 3 days after abdominal surgery. Additionally, the investigators investigated the appropriate target for protein provision in critically ill patients who undergo abdominal surgery.

Interventions

DIETARY_SUPPLEMENTActive protein supplementation

The participants in active nutritional supplementation arm received consultation from the nutritional support team (NST) upon ICU admission, and nutritional supplementation was initiated on the same day. NST is a multidisciplinary support team comprised of physicians, nurses, dietitians, and pharmacists, which assesses the nutritional status of patients, and provides recommendations for nutritional therapy. Targets in the participants in active protein supplementation arm were protein supplementation at over 1.5 g/kg/day during first 3 days after ICU admission. Actual body weight was used as the body weight for patients with a percent of ideal body weight (PIBW) of less than 120%, while adjusted body weight was used for patients with a PIBW greater than or equal to 120%.

DIETARY_SUPPLEMENTConventional protein supplementation

The participants in conventional protein supplementation arm received conservative nutritional management without specific protein targets.

Sponsors

Seoul St. Mary's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients admitted after abdominal surgery to our institution's surgical ICU * They were enrolled regardless of the surgical method, either open, laparoscopy, or robotic.

Exclusion criteria

* aged under 18 years * underwent surgery under local or regional anesthesia * pregnant * readmitted to the ICU due to any cause * diagnosed with renal failure and receiving renal replacement therapy * patients diagnosed with multiorgan failure, represented by a high Sequential Organ Failure Assessment (SOFA) score (≥9) upon ICU admission * failed to provide informed consent, or with 'do-not-resuscitate' status.

Design outcomes

Primary

MeasureTime frameDescription
6-month mortality rateParticipants were followed up to 180 days immediately after the surgeryProportion of patients who died within 6 months after surgery among participants

Secondary

MeasureTime frameDescription
30-day mortality rateParticipants were followed up to 30 days immediately after the surgeryProportion of patients who died within 30 days after surgery among participants
90-day mortality rateParticipants were followed up to 90 days immediately after the surgeryProportion of patients who died within 90 days after surgery among participants
Incidence of postoperative complicationsParticipants were followed during hospitalization (up to 14 days)Proportion of patients who developed any complications during postoperative hospitalization among participants

Countries

South Korea

Contacts

Primary ContactEun young Kim
freesshs@naver.com+82-10-4720-0246
Backup ContactHye sung Kim
dragon90@naver.com+82-10-6325-5910

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026